Clinical Trial Participation
INSYS Therapeutics is recognized for its advances surrounding a progressive line of innovative drugs and novel drug delivery systems that improve the quality of patients' lives.
Through our clinical team, we aim to develop cutting-edge therapies that set new standards in supportive care and cancer treatment. Our team is dedicated to exploring interventions, examining methods and measuring ways to improve the comfort and quality of patients' lives. Research participation is vital to our success.
|Compound||Area of Research|
|Fentanyl Sublingual Spray||Various Pain Types|
|Dronabinol Oral Solution||Nausea / Vomiting Associated with Cancer Chemotherapy and Anorexia / Weight Loss in Patients with AIDS|
|Cannabidiol||Dravet Syndrome and Lennox – Gastaut Syndrome|
|Buprenorphine Sublingual Spray||Moderate to Severe Pain|
|Buprenorphine Naloxone Sublingual Spray||Opioid Dependence|
|Naloxone Sublingual Spray||Reversal of Opioid Depression|
|Ondansetron Sublingual Spray||Prevention of Nausea and Vomiting|
|Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU)||Cervical and Cholangiocarcinoma|
For Physicians and/or Sites Interested in Clinical Trials
INSYS Therapeutics regularly reviews clinical trial research site, investigator and program information from interested parties. To be reviewed, site and investigator information should be submitted to INSYS via email at firstname.lastname@example.org.